X Bioscience PCL, formerly WOW Factor Public Company Limited, is a Thailand-based company. The Company is engaged in the business of investments. The Company is engaged in the food business with services delivering food experience of various nationalities to consumers in Thailand.

Employees

399

Sector

Financial & Commodity Market Operators

More about the company

Quotes

Date	Price	Change	Volume
26-11-11	THB 0.0400	0.00%	87,620
26-11-11	THB 0.0400	0.00%	264,340
26-11-10	THB 0.0400	0.00%	429,826
26-11-09	THB 0.0400	0.00%	208,164
26-11-06	THB 0.0400	0.00%	293,300

End-of-day quote Thailand S.E.

More quotes

End-of-day quote Thailand S.E. 2026-11-12			5-day change	1st Jan Change
0.0400 ^THB	0.00%		0.00%	-76.47%

10-30	X Bioscience Public Company Limited Announces CFO Changes	CI
10-30	X Bioscience Public Company Limited Announces CEO Changes	CI

Market Cap	487M 14.35M 12.98M 11.98M 10.84M 20.46M 1.35B 21.07M 144M 57.14M 721M 53.86M 52.71M 2.3B	P/E 2024	-2.62x	P/E 2025	-0.15x
Enterprise Value	722M 21.3M 19.26M 17.78M 16.1M 30.37M 2B 31.28M 213M 84.82M 1.07B 79.95M 78.25M 3.41B	EV / Sales 2024	4.31x	EV / Sales 2025	3.2x
Free-Float	8.55%	Yield 2024 *	-	Yield 2025	-

10-30	X Bioscience Public Company Limited Announces CFO Changes	CI
10-30	X Bioscience Public Company Limited Announces CEO Changes	CI
10-30	X Bioscience Public Company Limited Announces Management Changes	CI
09-29	X Bioscience Extends Deadline for Stake Sale in Fruita Biomed, Reduces Deal Price	MT
09-06	X Bioscience Public Company Limited agreed to acquire 51% stake in Fruita Biomed Company Limited from Ms. Satita Polsuwatti for approximately THB 170 million.	CI
08-16	X Bioscience Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-20	X Bioscience Reports Higher Impairment Charges in Q1	MT
07-16	X Bioscience Public Company Limited Announces CEO Changes	CI
07-16	X Bioscience Public Company Limited Announces Executive Changes and Restructure of Executive Committees	CI
07-15	X Bioscience Subsidiary Disposes of Entire Stake in Eastern Cuisine (Thailand)	MT
07-07	X Bioscience Public Company Limited Approves Address Change	CI
06-02	X Bioscience Public Company Limited Announces Appointment of Ramjai Sriporamin to Chief Financial Officer, Effective June 1, 2026	CI
06-02	X Bioscience Public Company Limited Announces Board Changes	CI

1 month	-20.00%
3 months	-42.86%
6 months	-55.56%
Current year	-76.47%

Wow Factor Stock

Stocks

XBIO

TH0753C10Z00

Financial & Commodity Market Operators

Valuation: Wow Factor

Chart: Wow Factor

Latest news: Wow Factor

Quotes and Performance

Price Extremes

Managers and Directors: Wow Factor

Other Financial & Commodity Market Operators

Financials

Company Profile

Quotes

1 week	0.03	0.04
1 month	0.03	0.05
Current year	0.03	0.18
1 year	0.03	0.23
3 years	0.03	6.79
5 years	0.03	33.32
10 years	0.03	147

Manager	Title	Age	Since
Sittichai Kritvivat CEO	Chief Executive Officer	-	2026-10-31
Sasitorn Ketphueak DFI	Director of Finance/CFO	41	2026-10-31
Anucha Ritpakdee CTO	Chief Tech/Sci/R&D Officer	-	2014-04-30

Director	Title	Age	Since
Saowanee Khaoubol BRD	Director/Board Member	51	2022-05-12
Phurit Wongkham BRD	Director/Board Member	40	2026-02-24
Sarayut Rueangsuwan BRD	Director/Board Member	43	2025-05-15

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WOW FACTOR	0.00%	0.00%	-78.95%	-99.21%	14.4M
CME GROUP INC.	-0.12%	+2.69%	+12.85%	+45.34%	113B
INTERCONTINENTAL EXCHANGE, INC.	-1.51%	+2.22%	+15.46%	+63.68%	101B
DEUTSCHE BÖRSE AG	-0.15%	+2.60%	+55.05%	+97.17%	65.51B
HONG KONG EXCHANGES AND CLEARING LIMITED	-0.42%	-0.52%	-12.26%	+35.17%	61.81B
NASDAQ, INC.	-0.94%	+1.70%	+22.39%	+108.58%	60.87B
LONDON STOCK EXCHANGE GROUP PLC	+0.89%	-0.67%	+5.86%	+13.68%	61.24B
NATIONAL STOCK EXCHANGE OF INDIA LIMITED	+2.25%	+9.96%	-	-	51.35B
TRADEWEB MARKETS INC.	+0.80%	+3.20%	+19.76%	+41.87%	27.31B
EURONEXT N.V.	-0.72%	-2.52%	+29.84%	+132.12%	18.89B
Average	+0.10%	+1.45%	+7.78%	+48.71%	56B
Weighted average by Cap.	-0.02%	+1.82%	+17.04%	+61.18%

	2024	2025
Net sales	319M 9.42M 8.51M 7.86M 7.11M 13.43M 885M 13.83M 94.34M 37.49M 473M 35.34M 34.59M 1.51B	130M 3.82M 3.46M 3.19M 2.89M 5.45M 360M 5.62M 38.31M 15.23M 192M 14.35M 14.05M 612M
Net income	-260M -7.68M -6.94M -6.41M -5.8M -10.94M -722M -11.27M -76.9M -30.56M -386M -28.81M -28.19M -1.23B	-469M -13.83M -12.51M -11.54M -10.45M -19.72M -1.3B -20.31M -139M -55.06M -695M -51.9M -50.8M -2.21B
Net Debt	345M 10.19M 9.21M 8.5M 7.7M 14.52M 958M 14.96M 102M 40.56M 512M 38.23M 37.42M 1.63B	236M 6.95M 6.29M 5.8M 5.25M 9.91M 654M 10.21M 69.65M 27.68M 349M 26.09M 25.53M 1.11B